-
Je něco špatně v tomto záznamu ?
Guanylhydrazone and semicarbazone derivatives as potential prototypes for the design of cholinesterase inhibitors against Alzheimer's disease: biological evaluation and molecular modeling studies
DCF. Neto, JSF. Diz, SJA. Guimarães, EM. Dos Santos, MDDSB. Nascimento, APS. de Azevedo-Santos, TCC. França, SR. LaPlante, CJ. do Nascimento, JA. Lima
Jazyk angličtina Země Irsko
Typ dokumentu časopisecké články
- MeSH
- acetylcholinesterasa metabolismus chemie MeSH
- Alzheimerova nemoc * farmakoterapie MeSH
- butyrylcholinesterasa metabolismus chemie MeSH
- cholinesterasové inhibitory * chemie farmakologie metabolismus terapeutické užití chemická syntéza MeSH
- hydrazony * chemie farmakologie MeSH
- kinetika MeSH
- lidé MeSH
- molekulární modely MeSH
- racionální návrh léčiv * MeSH
- semikarbazony * chemie farmakologie metabolismus MeSH
- simulace molekulového dockingu MeSH
- vztahy mezi strukturou a aktivitou MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
Despite being present in many drugs, guanylhydrazones and semicarbazones are two functional groups that have been little investigated as potential therapeutic strategies for the treatment of Alzheimer's disease (AD). For this reason, we initiated the synthesis and evaluation of these compounds as potential anticholinesterase agents, aiming to offer new alternatives for drug development against AD. In the severe phase of AD butyrylcholinesterase (BChE) becomes the main enzyme responsible for the hydrolysis of acetylcholine (ACh). Therefore, in this project, we present the results of BChE inhibitory activity, enzyme kinetics, cytotoxicity, and molecular modeling studies for three guanylhydrazone and two semicarbazone derivatives that were previously synthesized and evaluated as acetylcholinesterase (AChE) inhibitors. Among the compounds tested, guanylhydrazones (1, 2, and 3) showed inhibitory activity against BChE, exhibiting a mixed non-competitive inhibition profile. Specifically, compound 2 (phenanthrenequinone) demonstrated superior inhibitory potency with an IC50 of 0.68 μM, compared to compound 1 (acridinone) with an IC50 of 3.87 μM, and compound 3 (benzodioxole) with an IC50 of 101.7 μM. In contrast, semicarbazones (4 and 5) showed no BChE inhibition up to the highest concentration tested (300 μM). Importantly, all five compounds were found to be non-cytotoxic. Our results suggest that these compounds have potential as drug prototypes targeting different phases of AD. Compounds 3, 4, and 5 may be more effective in the early phase, when AChE activity remains high; compound 1 could be useful in the intermediate phase; and compound 2 appears particularly promising for the severe phase, when BChE plays a more dominant role.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25015200
- 003
- CZ-PrNML
- 005
- 20250731090828.0
- 007
- ta
- 008
- 250708e20250415ie f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.cbi.2025.111515 $2 doi
- 035 __
- $a (PubMed)40246050
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ie
- 100 1_
- $a Neto, Denise Cristian Ferreira $u Medicinal Chemistry Group, Department of Chemistry, Military Institute of Engineering, Praça General Tibúrcio 80, 22290-270, Rio de Janeiro, RJ, Brazil; Department of Chemistry, Federal University of Roraima, Av. Cap. Ene Garcês, 2413, 69310-000, Boa Vista, Roraima, Brazil. Electronic address: denisecristian@ime.eb.br
- 245 10
- $a Guanylhydrazone and semicarbazone derivatives as potential prototypes for the design of cholinesterase inhibitors against Alzheimer's disease: biological evaluation and molecular modeling studies / $c DCF. Neto, JSF. Diz, SJA. Guimarães, EM. Dos Santos, MDDSB. Nascimento, APS. de Azevedo-Santos, TCC. França, SR. LaPlante, CJ. do Nascimento, JA. Lima
- 520 9_
- $a Despite being present in many drugs, guanylhydrazones and semicarbazones are two functional groups that have been little investigated as potential therapeutic strategies for the treatment of Alzheimer's disease (AD). For this reason, we initiated the synthesis and evaluation of these compounds as potential anticholinesterase agents, aiming to offer new alternatives for drug development against AD. In the severe phase of AD butyrylcholinesterase (BChE) becomes the main enzyme responsible for the hydrolysis of acetylcholine (ACh). Therefore, in this project, we present the results of BChE inhibitory activity, enzyme kinetics, cytotoxicity, and molecular modeling studies for three guanylhydrazone and two semicarbazone derivatives that were previously synthesized and evaluated as acetylcholinesterase (AChE) inhibitors. Among the compounds tested, guanylhydrazones (1, 2, and 3) showed inhibitory activity against BChE, exhibiting a mixed non-competitive inhibition profile. Specifically, compound 2 (phenanthrenequinone) demonstrated superior inhibitory potency with an IC50 of 0.68 μM, compared to compound 1 (acridinone) with an IC50 of 3.87 μM, and compound 3 (benzodioxole) with an IC50 of 101.7 μM. In contrast, semicarbazones (4 and 5) showed no BChE inhibition up to the highest concentration tested (300 μM). Importantly, all five compounds were found to be non-cytotoxic. Our results suggest that these compounds have potential as drug prototypes targeting different phases of AD. Compounds 3, 4, and 5 may be more effective in the early phase, when AChE activity remains high; compound 1 could be useful in the intermediate phase; and compound 2 appears particularly promising for the severe phase, when BChE plays a more dominant role.
- 650 12
- $a cholinesterasové inhibitory $x chemie $x farmakologie $x metabolismus $x terapeutické užití $x chemická syntéza $7 D002800
- 650 12
- $a Alzheimerova nemoc $x farmakoterapie $7 D000544
- 650 12
- $a semikarbazony $x chemie $x farmakologie $x metabolismus $7 D012664
- 650 12
- $a hydrazony $x chemie $x farmakologie $7 D006835
- 650 _2
- $a butyrylcholinesterasa $x metabolismus $x chemie $7 D002091
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a acetylcholinesterasa $x metabolismus $x chemie $7 D000110
- 650 _2
- $a simulace molekulového dockingu $7 D062105
- 650 12
- $a racionální návrh léčiv $7 D015195
- 650 _2
- $a kinetika $7 D007700
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 650 _2
- $a molekulární modely $7 D008958
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Diz, Joyce Sobreiro Francisco $u Laboratory of Molecular Modeling Applied to the Chemical and Biological Defense (LMCBD), Military Institute of Engineering (IME), Praça General Tibúrcio 80, 22290-270, Rio de Janeiro, Brazil; Institute of Chemical, Biological, Radiological and Nuclear Defense (IDQBRN), Brazilian Army Technological Center (CTEx), Av. das Américas 28705, Área 4, 23020-470, Rio de Janeiro, RJ, Brazil
- 700 1_
- $a Guimarães, Sulayne Janayna Araújo $u Laboratory for Applied Cancer Immunology, Biological and Health Sciences Center, Federal University of Maranhão, Avenida dos Portugueses, 1966, Bacanga, 65080-805, São Luís, Maranhão, Brazil
- 700 1_
- $a Dos Santos, Eduardo Mendes $u Federal University of Maranhão, Postgraduate Program in Adult Health (PPGSAD), Avenida dos Portugueses, 1966, Bacanga, 65080-805, São Luís, Maranhão, Brazil
- 700 1_
- $a Nascimento, Maria do Desterro Soares Brandão $u Federal University of Maranhão, Postgraduate Program in Adult Health (PPGSAD), Avenida dos Portugueses, 1966, Bacanga, 65080-805, São Luís, Maranhão, Brazil
- 700 1_
- $a de Azevedo-Santos, Ana Paula Silva $u Laboratory for Applied Cancer Immunology, Biological and Health Sciences Center, Federal University of Maranhão, Avenida dos Portugueses, 1966, Bacanga, 65080-805, São Luís, Maranhão, Brazil
- 700 1_
- $a França, Tanos Celmar Costa $u Laboratory of Molecular Modeling Applied to the Chemical and Biological Defense (LMCBD), Military Institute of Engineering (IME), Praça General Tibúrcio 80, 22290-270, Rio de Janeiro, Brazil; Université de Québec, INRS - Centre Armand-Frappier Santé Biotechnologie, 531 boulevard des Prairies, Laval, Québec, H7V 1B7, Canada; Center for Basic and Applied Research, Faculty of Informatics and Management, University of Hradec Kralove, 50003, Hradec Kralove, Czech Republic
- 700 1_
- $a LaPlante, Steven R $u Université de Québec, INRS - Centre Armand-Frappier Santé Biotechnologie, 531 boulevard des Prairies, Laval, Québec, H7V 1B7, Canada
- 700 1_
- $a do Nascimento, Claudia Jorge $u Institute of Biosciences, Federal University of the State of Rio de Janeiro, Av. Pasteur, 296, Urca, 22290-250, Rio de Janeiro, Brazil
- 700 1_
- $a Lima, Josélia Alencar $u Federal University of Maranhão, Postgraduate Program in Adult Health (PPGSAD), Avenida dos Portugueses, 1966, Bacanga, 65080-805, São Luís, Maranhão, Brazil. Electronic address: joselialima@terra.com.br
- 773 0_
- $w MED00002111 $t Chemico-biological interactions $x 1872-7786 $g Roč. 415 (20250415), s. 111515
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/40246050 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250708 $b ABA008
- 991 __
- $a 20250731090822 $b ABA008
- 999 __
- $a ok $b bmc $g 2366198 $s 1252325
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 415 $c - $d 111515 $e 20250415 $i 1872-7786 $m Chemico-biological interactions $n Chem Biol Interact $x MED00002111
- LZP __
- $a Pubmed-20250708